| Issue Date | Title | Author(s) |
| 2014 | An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia | Huang, Xinfang; Du, Hui; Gu, Jieruo; Zhao, Dongbao; Jiang, Lindi; Li, Xinfu; Zuo, Xiaoxia; Liu, Yi; Li, Zhanguo; Li, Xiangpei; Zhu, Ping; Li, Juan; Zhang, Zhiyi; Huang, Anbin; Zhang, Yuanchao; Bao, Chunde |
| 2017 | Association Analysis of the MHC in Lupus Nephritis | Xu, Ricong; Li, Qibin; Liu, Rongjun; Shen, Juan; Li, Ming; Zhao, Minghui; Wang, Meng; Liao, Qijun; Mao, Haiping; Li, Zhijian; Zhou, Na; Yin, Peiran; Li, Yue; Tang, Xueqing; Wu, Tian; Zhong, Zhong; Wang, Yan; Ai, Zhen; Wang, Ou; Chen, Na; Yang, Xiaoqin; Fang, Junbin; Fu, Ping; Gu, Jieruo; Ye, Kun; Chen, Jian; Dai, Lie; Liu, Huafeng; Liu, Zhangsuo; Liao, Yunhua; Wan, Jianxin; Ding, Guohua; Zhao, Jinghong; Zhang, Hao; Fu, Shuxia; Sun, Liangdan; Zhang, Xuejun; Yang, Huanming; Wang, Jian; Wang, Jun; Liu, Jianjun; Li, Yingrui; Yu, Xueqing |
| 16-Sep-2020 | Can low-dose methotrexate reduce effusion-synovitis and symptoms in patients with mid- to late-stage knee osteoarthritis? Study protocol for a randomised, double-blind, and placebo-controlled trial | Zhu, Zhaohua; Yu, Qinghong; Leng, Xiaomei; Han, Weiyu; Li, Zhanguo; Huang, Cibo; Gu, Jieruo; Zhao, Yi; Wang, Kang; Li, Tianwang; Mei, Yifang; Xu, Jianhua; Zhang, Zhiyi; Hunter, David; Cicuttini, Flavia; Zeng, Xiaofeng; Ding, Changhai |
| 2009 | A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China | Hu, Dawei; Bao, Chunde; Chen, Shunle; Gu, Jieruo; Li, Zhanguo; Sun, Lingyun; Han, Xinghai; Ni, Liqing |
| 2015 | Cross-sectional comparison of ultrasonography scoring systems for primary Sjogren's syndrome | Lin, Dongfang; Yang, Weiqiang; Guo, Xinghua; Cao, Junyan; Lv, Qing; Jin, Ou; Wu, Yuqiong; Gu, Jieruo |
| Oct-2023 | Efficacy and Safety of LNK01001 in Chinese Patients with Moderate to Severe Active Rheumatoid Arthritis with an Inadequate Response to Conventional Synthetic DMARDs: 24-week Results from a Phase 2 Trial | Wu, Chanyuan; Wang, Xuebin; Hu, Jiankang; Shi, Xiaofei; Wang, Xiaoxia; Zhang, Xuan; Liu, Ju; Rao, Hui; Zhao, Jianhong; Du, Rong; Jiang, Zhenyu; Liu, Huaxiang; Liu, Lin; Liu, Shengyun; Xie, Changhao; Liao, Xiangping; Dai, Lie; Hou, Zhiduo; Jin, Jingchun; Li, Tianwang; Meng, Deqian; Wang, Yongfu; Wu, Jian; Gu, Jieruo; Wei, Wei; Zhuang, Yu; Wang, Kuanting; Zhang, Rong; Zhang, Xiao; Wei, Huaping; Wan, Zhao-Kui; Wang, Jun; Vazquez, Michael; Wu, Henry; Zeng, Xiaofeng |
| 2019 | Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study | Qian, Junyan; Li, Mengtao; Zhang, Xiao; Wang, Qian; Zhao, Jiuliang; Tian, Zhuang; Wei, Wei; Zuo, Xiaoxia; Zhang, Miaojia; Zhu, Ping; Ye, Shuang; Zhang, Wei; Zheng, Yi; Qi, Wufang; Li, Yang; Zhang, Zhuoli; Ding, Feng; Gu, Jieruo; Liu, Yi; Wang, Yanhong; Zeng, Xiaofeng |
| Apr-2022 | Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years | Zhang, Fengchun; Zheng, Jie; Li, Yang; Wang, Guochun; Wang, Mingjun; Su, Yin; Gu, Jieruo; Li, Xingfu; Bass, Damon; Chu, Myron; Curtis, Paula; DeRose, Kathleen; Kurrasch, Regina; Lowe, Jenny; Meizlik, Paige; Roth, David A. |
| 2019 | Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors | Zhang, Na; Li, Mengtao; Qian, Junyan; Wang, Qian; Zhao, Jiuliang; Yang, Zhenwen; Tian, Zhuang; Zhang, Xiao; Zuo, Xiaoxia; Zhang, Miaojia; Zhu, Ping; Ye, Shuang; Zhang, Wei; Zheng, Yi; Qi, Wufang; Li, Yang; Zhang, Zhuoli; Ding, Feng; Gu, Jieruo; Liu, Yi; Wei, Wei; Zeng, Xiaofeng |
| 2017 | Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study | Bi, Liqi; Li, Yuhui; He, Lan; Xu, Huji; Gu, Jieruo; Wang, Guochun; Zhang, Zhiyi; Liu, Yi; Boehnlein, Marion; Dunkel, Jochen; Shao, Jing; Harris, Kristina; Li, Zhanguo |
| 2013 | Safety of infliximab therapy in rheumatoid arthritis patients with previous exposure to hepatitis B virus | Zhang, Xuewu; Zhang, Fengchun; Wu, Donghai; Bao, Chunde; Zhu, Ping; Zhang, Xiao; Huang, Cibo; He, DongYi; Tao, Yi; Fang, Yongfei; Gu, Jieruo; Wu, Huaxiang; Sun, Lingyun; Yang, Xiuyan; Huang, Feng; Xu, Huji; Zhao, Dongbao; Zhang, Miaojia; Zheng, Yi; Li, Zhanguo |
